Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.57) per share. This is a 280 percent decrease over losses of $(0.15) per share from the same period last year.
Capital One Downgrades Summit Hotel Properties to Equal-Weight, Lowers Price Target to $10
Capital One analyst Neil Malkin downgrades Summit Hotel Properties (NYSE:INN) from Overweight to Equal-Weight and lowers the price target from $14 to $10.